Anti-Cancer Agent “Xeloda®”, Obtained Approval for Additional Indication of “Adjuvant Chemotherapy for Rectal Cancer”
2016-08-26
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.
Investors
Investor updates
stay updated
get the latest news and updates to your inbox.